These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

8223 related articles for article (PubMed ID: 10660099)

  • 1. A new member of the GTPase superfamily that is upregulated in highly metastatic cells.
    Nakaji T; Kataoka TR; Watabe K; Nishiyama K; Nojima H; Shimada Y; Sato F; Matsushima H; Endo Y; Kuroda Y; Kitamura Y; Ito A; Maeda S
    Cancer Lett; 1999 Dec; 147(1-2):139-47. PubMed ID: 10660099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Annexin VII as a novel marker for invasive phenotype of malignant melanoma.
    Kataoka TR; Ito A; Asada H; Watabe K; Nishiyama K; Nakamoto K; Itami S; Yoshikawa K; Ito M; Nojima H; Kitamura Y
    Jpn J Cancer Res; 2000 Jan; 91(1):75-83. PubMed ID: 10744047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-dose tumour necrosis factor-alpha (TNF-alpha) and melphalan in hyperthermic isolated limb perfusion. Results from a pilot study performed in the United Kingdom.
    Hill S; Thomas JM
    Melanoma Res; 1994 Mar; 4 Suppl 1():31-4. PubMed ID: 8038593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Importance of repair of potentially lethal damage in assays of cytotoxic agents.
    Richie JP; Weichselbaum RR; Little JB
    Surgery; 1982 Aug; 92(2):380-4. PubMed ID: 7101131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary malignant melanoma of the external auditory canal extending into the preauricular area and scalp.
    Dutta M; Ghatak S; Sinha R
    Ear Nose Throat J; 2014; 93(10-11):E12-4. PubMed ID: 25397381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Will targeted therapies replace chemotherapy?].
    Collignon J; Jerusalem G
    Rev Med Liege; 2012; 67 Spec No():29-36. PubMed ID: 22690483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapeutic effects of survivinT34A mutants on pulmonary metastases of melanoma B16 in mice].
    Zhang L; Li ZY; Wang CT
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 May; 42(3):313-6. PubMed ID: 21826989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Changes of immune function in patients with 2009 influenza A (H1N1)].
    Li CR; Yang J; Jia SL; Wang GB; He YX; Zu Y; Yang WG; Fu D
    Zhonghua Er Ke Za Zhi; 2010 Dec; 48(12):947-53. PubMed ID: 21215192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determinants of human and mouse melanoma cell sensitivities to oleandrin.
    Lin Y; Dubinsky WP; Ho DH; Felix E; Newman RA
    J Exp Ther Oncol; 2008; 7(3):195-205. PubMed ID: 19066128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A rare conjunctival Spitz nevus: a case report and literature review.
    Vervaet N; Van Ginderdeuren R; Van Den Oord JJ; Foets B
    Bull Soc Belge Ophtalmol; 2007; (303):63-7. PubMed ID: 17894290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized controlled study of electrochemotherapy in the local treatment of skin metastases of melanoma.
    Gaudy C; Richard MA; Folchetti G; Bonerandi JJ; Grob JJ
    J Cutan Med Surg; 2006; 10(3):115-21. PubMed ID: 17241586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adoptive cell therapy for metastatic melanoma patients: pre-clinical development at the Sheba Medical Center.
    Besser MJ; Treves AJ; Itzhaki O; Hardan I; Nagler A; Papa MZ; Catane R; Winkler E; Shalmon-Zifroni B; Schachter J
    Isr Med Assoc J; 2006 Mar; 8(3):164-8. PubMed ID: 16599050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of biologically active human TRAIL in transgenic pigs.
    Klose R; Kemter E; Bedke T; Bittmann I; Kelsser B; Endres R; Pfeffer K; Schwinzer R; Wolf E
    Transplantation; 2005 Jul; 80(2):222-30. PubMed ID: 16041267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pseudolaric acid B induces human melanoma A375-S2 cell apoptosis in vitro].
    Gong XF; Wang MW; Tashiro S; Onodera S; Ikejima T
    Zhongguo Zhong Yao Za Zhi; 2005 Jan; 30(1):55-7. PubMed ID: 15714803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of intraperitoneal cisplatin and doxorubicin.
    Rossi CR; Mocellin S; Pilati P; Foletto M; Quintieri L; Palatini P; Lise M
    Surg Oncol Clin N Am; 2003 Jul; 12(3):781-94. PubMed ID: 14567031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-2-Activated Killer Cells and Native Cytokines in Treatment of Patients with Advanced Cancer.
    Ostanin AA; Chernykh HR; Leplina OY; Shevela EY; Niconov SD; Kozlov VA
    Russ J Immunol; 1997 Dec; 2(3-4):167-176. PubMed ID: 12687071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Facts and pitfalls in the detection of tyrosinase mRNA in the blood of melanoma patients by RT-PCR.
    Seiter S; Rappl G; Tilgen W; Ugurel S; Reinhold U
    Recent Results Cancer Res; 2001; 158():105-12. PubMed ID: 11092037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic and epidemiological risk factors for a malignant melanoma-predisposing phenotype: the great number of nevi.
    Briollais L; Chompret A; Guilloud-Bataille M; Feingold N; Avril MF; Demenais F
    Genet Epidemiol; 1996; 13(4):385-402. PubMed ID: 8894641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenoviral-mediated herpes simplex virus-thymidine kinase gene transfer in vivo for treatment of experimental human melanoma.
    Bonnekoh B; Greenhalgh DA; Bundman DS; Kosai K; Chen SH; Finegold MJ; Krieg T; Woo SL; Roop R
    J Invest Dermatol; 1996 Jun; 106(6):1163-8. PubMed ID: 8752651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Panophthalmitis with acute scleral necrosis after brachytherapy of a malignant melanoma of the ciliary body.
    Bodanowitz S; Strempel I; Wiegand W; Kroll P
    Ger J Ophthalmol; 1995 Nov; 4(6):380-2. PubMed ID: 8751105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 412.